Research Report University Hospital for clinical assessment TPU-TAS-102-301

Abstract

Randomized, Double-blind, Phase 3 Study of TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Keywords

• Metastatic Colorectal Cancer
• TAS-102